Simplex Trading’s Strongbridge Biopharma plc. SBBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-63,000
Closed -$24K 11999
2021
Q3
$24K Hold
63,000
﹤0.01% 8301
2021
Q2
$187K Buy
63,000
+62,754
+25,510% +$166K ﹤0.01% 5792
2021
Q1
$67K Buy
246
+179
+267% +$540 ﹤0.01% 6265
2020
Q4
$16K Buy
+67
New +$161 ﹤0.01% 7143
2020
Q3
Sell
-24
Closed -$9K 8853
2020
Q2
$9K Sell
24
-5
-17% -$15 ﹤0.01% 6740
2020
Q1
$5K Buy
+29
New +$75 ﹤0.01% 6903
2019
Q4
Sell
-28
Closed -$6K 8277
2019
Q3
$6K Hold
28
﹤0.01% 6567
2019
Q2
$8K Buy
+28
New +$103 ﹤0.01% 6264
2019
Q1
Sell
-77
Closed -$34K 8178
2018
Q4
$34K Buy
77
+38
+97% +$186 ﹤0.01% 4912
2018
Q3
$18K Buy
+39
New +$200 ﹤0.01% 6058

Simplex Trading's SBBP Position: Q2 2021 in Review

Simplex Trading sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 241 shares — an estimated $636 sold.

Simplex Trading first reported a position in SBBP in Q1 2019 and held it in 5 quarters. The position peaked at $33K in Q3 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Simplex Trading reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Simplex Trading sold 241 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $636.
  • Simplex Trading first reported a position in Strongbridge Biopharma plc. in Q1 2019 and held it in 5 quarters.
  • Simplex Trading's Strongbridge Biopharma plc. position peaked at $33K in Q3 2020.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.